Codexis Inc stock is traded at $0.9764, with a volume of 1,667,547. It is down -2.36% in the last 24 hours and down -30.75% over the past month. Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
Previous Close:
$1.00
Open:
$1.00
24h Volume:
1,667,547
Relative Volume:
1.97
Market Cap:
$106.92M
Revenue:
$78.09M
Net Income/Loss:
-$31.99M
P/E Ratio:
-
EPS:
-$0.363
Net Cash Flow:
-$22.12M
1W Performance:
-4.27%
1M Performance:
-30.75%
6M Performance:
-61.56%
1Y Performance:
-49.41%
1-Day Range:
$0.95$1.02
1-Week Range:
$0.95$1.17
52-Week Range:
$0.95$2.98
Codexis Inc Stock (CDXS) Company Profile
Name
Codexis IncSector
HealthcareIndustry
BiotechnologyPhone
650-421-8100Address
200 PENOBSCOT DRIVE, REDWOOD CITY, CA, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS